The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. Strong experience with HR systems and technology, including Workday and VNDLY or similar VMS platforms, with an understanding of system integrations, workflows, data dependencies, and downstream impacts, including experience supporting system enhancements, testing, and implementation activities.